These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 36122562)
1. Autoantibodies against Central Nervous System Antigens and the Serum Levels of IL-32 in Patients with Schizophrenia. Keshavarz F; Soltani M; Mokhtarian K; Beshkar P; Majidi J; Azadegan-Dehkordi F; Anjomshoa M; Bagheri N Neuroimmunomodulation; 2022; 29(4):493-499. PubMed ID: 36122562 [TBL] [Abstract][Full Text] [Related]
2. A Study of Autoantibodies against Some Central Nervous System Antigens and the IL-35 Serum Level in Schizophrenia. Soltani M; Beshkar P; Mokhtarian K; Anjomshoa M; Mohammad-Rezaei M; Azadegan-Dehkordi F; Mirzaei Y; Majidi J; Bagheri N Iran J Allergy Asthma Immunol; 2022 Aug; 21(4):441-448. PubMed ID: 36243932 [TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of autoantibodies against brain antigens in health and disease. Dahm L; Ott C; Steiner J; Stepniak B; Teegen B; Saschenbrecker S; Hammer C; Borowski K; Begemann M; Lemke S; Rentzsch K; Probst C; Martens H; Wienands J; Spalletta G; Weissenborn K; Stöcker W; Ehrenreich H Ann Neurol; 2014 Jul; 76(1):82-94. PubMed ID: 24853231 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic approaches in antibody-associated central nervous system pathologies. Honnorat J Rev Neurol (Paris); 2014 Oct; 170(10):587-94. PubMed ID: 25189679 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of potential prevalence of onconeural antibodies in women with breast cancer. Krolewska-Daszczynska P; Smycz-Kubanska M; Kruszniewska-Rajs C; Kabut J; Olczyk P; Gola J; Mielczarek-Palacz A Pol Merkur Lekarski; 2024; 52(1):5-9. PubMed ID: 38518226 [TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid, antineuronal autoantibody, EEG, and MRI findings from 992 patients with schizophreniform and affective psychosis. Endres D; Meixensberger S; Dersch R; Feige B; Stich O; Venhoff N; Matysik M; Maier SJ; Michel M; Runge K; Nickel K; Urbach H; Domschke K; Prüss H; Tebartz van Elst L Transl Psychiatry; 2020 Aug; 10(1):279. PubMed ID: 32782247 [TBL] [Abstract][Full Text] [Related]
7. Clinical Impact of Pre-Existing Autoantibodies in Patients With SCLC Treated With Immune Checkpoint Inhibitor: A Multicenter Prospective Observational Study. Sato Y; Fujiwara S; Hata A; Kida Y; Masuda T; Amimoto H; Matsumoto H; Miyoshi K; Otsuka K; Tomii K JTO Clin Res Rep; 2023 Dec; 4(12):100608. PubMed ID: 38162177 [TBL] [Abstract][Full Text] [Related]
9. Expression of glutamic acid decarboxylase in nervous tissue structures targeted by autoantibodies in patients with diabetic autonomic neuropathy. Zanone MM; Petersen JS; Vergani D; Peakman M J Neuroimmunol; 1997 Sep; 78(1-2):1-7. PubMed ID: 9307223 [TBL] [Abstract][Full Text] [Related]
10. A study of type-1 diabetes associated autoantibodies in schizophrenia. Hallford P; Clair DS; Halley L; Mustard C; Wei J Schizophr Res; 2016 Oct; 176(2-3):186-190. PubMed ID: 27474348 [TBL] [Abstract][Full Text] [Related]
11. Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case. Jarius S; Metz I; König FB; Ruprecht K; Reindl M; Paul F; Brück W; Wildemann B Mult Scler; 2016 Oct; 22(12):1541-1549. PubMed ID: 26869529 [TBL] [Abstract][Full Text] [Related]
12. Autoantibodies Against Ubiquitous and Confined Antigens in Patients With Ocular, Neuro-Ophthalmic and Congenital Cerebral Toxoplasmosis. Goldberg-Murow M; Cedillo-Peláez C; Concha-Del-Río LE; Cheja-Kalb R; Salgar-Henao MJ; Orozco-Velasco E; Luna-Pastén H; Gómez-Chávez F; Ibarra A; Correa D Front Immunol; 2021; 12():606963. PubMed ID: 34054794 [No Abstract] [Full Text] [Related]
13. Anti-neuronal anti-bodies in patients with early psychosis. Mantere O; Saarela M; Kieseppä T; Raij T; Mäntylä T; Lindgren M; Rikandi E; Stoecker W; Teegen B; Suvisaari J Schizophr Res; 2018 Feb; 192():404-407. PubMed ID: 28461116 [TBL] [Abstract][Full Text] [Related]
14. Antineuronal autoantibodies in neurological disorders. Bürk K Biomol Concepts; 2011 Jun; 2(3):149-57. PubMed ID: 25962025 [TBL] [Abstract][Full Text] [Related]
15. A large screen for paraneoplastic neurological autoantibodies; diagnosis and predictive values. Seluk L; Taliansky A; Yonath H; Gilburd B; Amital H; Shoenfeld Y; Kivity S Clin Immunol; 2019 Feb; 199():29-36. PubMed ID: 30543927 [TBL] [Abstract][Full Text] [Related]
16. Cytokines as a marker of central nervous system autoantibody associated epilepsy. Gillinder L; McCombe P; Powell T; Hartel G; Gillis D; Rojas IL; Radford K Epilepsy Res; 2021 Oct; 176():106708. PubMed ID: 34271300 [TBL] [Abstract][Full Text] [Related]
17. [Plasma levels of interleukin-1beta, interleukin-2 and interleukin-4 in recently diagnosed type 1 diabetic children and their association with beta-pancreatic autoantibodies]. Pérez F; Oyarzún A; Carrasco E; Angel B; Albala C; Santos JL Rev Med Chil; 2004 Apr; 132(4):413-20. PubMed ID: 15382512 [TBL] [Abstract][Full Text] [Related]